Cu,Zn-SOD deficiency induces the accumulation of hepatic collagen

Free Radical Research

Volumn 50, Issue 6, 2016, Pages 666-677

  Sakiyama, Haruhiko ^a   Fujiwara, Noriko ^a   Yoneoka, Yuka ^a   Yoshihara, Daisaku ^a   Eguchi, Hironobu ^a   Suzuki, Keiichiro ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

AGE; liver fibrosis; MMP; SOD1; TIMP

Indexed keywords

ADVANCED GLYCATION END PRODUCT; COLLAGEN; COPPER ZINC SUPEROXIDE DISMUTASE; HEAT SHOCK PROTEIN 47; MATRIX METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; COPPER; SUPEROXIDE DISMUTASE; ZINC;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLLAGEN DEGRADATION; COLLAGEN SYNTHESIS; CONTROLLED STUDY; ENZYME DEFICIENCY; LIVER; LIVER FIBROSIS; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; WILD TYPE; ANIMAL; C57BL MOUSE; DEFICIENCY; DISEASE MODEL; METABOLISM;

ANIMALS; COLLAGEN; COPPER; DISEASE MODELS, ANIMAL; LIVER; MICE; MICE, INBRED C57BL; SUPEROXIDE DISMUTASE; ZINC;

EID: 84965080889     PISSN: 10715762     EISSN: 10292470     Source Type: Journal    
DOI: 10.3109/10715762.2016.1164856     Document Type: Article

References (55)

1. O.A.Gressner, R.Weiskirchen, A.M.Gressner Evolving concepts of liver fibrogenesis provide new diagnostic and therapeutic options. Comp Hepatol 2007;6:7.
2. B.Eyden The myofibroblast: Phenotypic characterization as a prerequisite to understanding its functions in translational medicine. J Cell Mol Med 2008;12:22–37.
3. M.A.Watsky, K.T.Weber, Y.Sun, A.Postlethwaite New insights into the mechanism of fibroblast to myofibroblast transformation and associated pathologies. Int Rev Cell Mol Biol 2010;282:165–192.
4. D.A.Brenner, T.Kisseleva, D.Scholten, Y.H.Paik, K.Iwaisako, S.Inokuchi,. Origin of myofibroblasts in liver fibrosis. Fibrogenesis tissue Repair 2012;5:S17.
5. N.C.Avery, A.J.Bailey The effects of the Maillard reaction on the physical properties and cell interactions of collagen. Pathol biol. 2006;54: 387–395.
6. N.C.Avery, A.J.Bailey Enzymic and non-enzymic cross-linking mechanisms in relation to turnover of collagen: Relevance to aging and exercise. Scand J Med Sci sports 2005;15:231–240.
7. H.Odani, K.Iijima, M.Nakata, S.Miyata, H.Kusunoki, Y.Yasuda,. Identification of N(omega)-carboxymethylarginine, a new advanced glycation endproduct in serum proteins of diabetic patients: Possibility of a new marker of aging and diabetes, Biochem Biophys Res Commun 2001;285:1232–1236.
8. N.Shangari, W.R.Bruce, R.Poon, P.J.O’Brien Toxicity of glyoxals – role of oxidative stress, metabolic detoxification and thiamine deficiency. Biochem Soc Trans 2003;31:1390–1393.
9. M.X.Fu, J.R.Requena, A.J.Jenkins, T.J.Lyons, J.W.Baynes, S.R.Thorpe The advanced glycation end product, Nepsilon-(carboxymethyl)lysine, is a product of both lipid peroxidation and glycoxidation reactions. J Biol Chem 1996;271:9982–9986.
10. O.James, C.Day Non-alcoholic steatohepatitis: Another disease of affluence. Lancet 1999;353:1634–1636.
11. C.P.Day, O.F.James Steatohepatitis: A tale of two “hits”? Gastroenterology 1998;114:842–845.
12. N.Chalasani, M.A.Deeg, D.W.Crabb Systemic levels of lipid peroxidation and its metabolic and dietary correlates in patients with nonalcoholic steatohepatitis. Am J Gastroenterol 2004;99:1497–1502.
13. Z.Yesilova, H.Yaman, C.Oktenli, A.Ozcan, A.Uygun, E.Cakir,. Systemic markers of lipid peroxidation and antioxidants in patients with nonalcoholic Fatty liver disease. Am J Gastroenterol 2005;100:850–855.
14. S.Narasimhan, K.Gokulakrishnan, R.Sampathkumar, S.Farooq, R.Ravikumar, V.Mohan, M.Balasubramanyam Oxidative stress is independently associated with non-alcoholic fatty liver disease (NAFLD) in subjects with and without type 2 diabetes. Clin Biochem 2010;43:815–821.
15. K.H.Gaens, P.M.Niessen, S.S.Rensen, W.A.Buurman, J.W.Greve, A.Driessen,. Endogenous formation of Nepsilon-(carboxymethyl)lysine is increased in fatty livers and induces inflammatory markers in an in vitro model of hepatic steatosis. J Hepatol 2012;56:647–655.
16. C.P.Oliveira, L.C.Gayotto, C.Tatai, B.I.Della Nina, E.S.Lima, D.S.Abdalla,. Vitamin C and vitamin E in prevention of nonalcoholic fatty liver disease (NAFLD) in choline deficient diet fed rats. Nutr J 2003;2:9.
17. H.Nakano, H.Nagasaki, A.Barama, K.Boudjema, D.Jaeck, K.Kumada,. The effects of N-acetylcysteine and anti-intercellular adhesion molecule-1 monoclonal antibody against ischemia-reperfusion injury of the rat steatotic liver produced by a choline-methionine-deficient diet. Hepatology 1997;26:670–678.
18. H.Nakano, H.Nagasaki, K.Yoshida, G.Kigawa, Y.Fujiwara, N.Kitamura,. N-Acetylcysteine and anti-ICAM-1 monoclonal antibody reduce ischemia-reperfusion injury of the steatotic rat liver. Transplant Proc 1998;30:3763.
19. K.Begriche, J.Massart, M.A.Robin, F.Bonnet, B.Fromenty Mitochondrial adaptations and dysfunctions in nonalcoholic fatty liver disease. Hepatology 2013;58:1497–1507.
20. M.E.Gurney, H.Pu, A.Y.Chiu, M.C.Dal Canto, C.Y.Polchow, D.D.Alexander,. Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation. Science 1994;264:1772–1775.
21. M.E.Ripps, G.W.Huntley, P.R.Hof, J.H.Morrison, J.W.Gordon Transgenic mice expressing an altered murine superoxide dismutase gene provide an animal model of amyotrophic lateral sclerosis. Proc Natl Acad Sci USA 1995;92:689–693.
22. Y.Iuchi, F.Okada, K.Onuma, T.Onoda, H.Asao, M.Kobayashi, J.Fujii Elevated oxidative stress in erythrocytes due to a SOD1 deficiency causes anaemia and triggers autoantibody production. Biochem J 2007;402:219–227.
23. D.Yoshihara, N.Fujiwara, T.Ookawara, S.Kato, H.Sakiyama, S.Yokoe,. Protective role of glutathione S-transferase A4 induced in copper/zinc-superoxide dismutase knockout mice. Free Rad Biol Med 2009;47:559–567.
24. K.K.Ohlemiller, S.L.McFadden, D.L.Ding, D.G.Flood, A.G.Reaume, E.K.Hoffman,. Targeted deletion of the cytosolic Cu/Zn-superoxide dismutase gene (SOD1) increases susceptibility to noise-induced hearing loss. Audiol Neuro-Otol 1999;4:237–246.
25. M.M.Matzuk, L.Dionne, Q.Guo, T.R.Kumar, R.M.Lebovitz Ovarian function in superoxide dismutase 1 and 2 knockout mice. Endocrinology 1998;139:4008–4011.
26. S.Uchiyama, T.Shimizu, T.Shirasawa CuZn-SOD deficiency causes ApoB degradation and induces hepatic lipid accumulation by impaired lipoprotein secretion in mice. J Biol Chem 2006;281:31713–31719.
27. L.Wang, Z.Jiang, X.G.Lei Knockout of SOD1 alters murine hepatic glycolysis, gluconeogenesis, and lipogenesis. Free Rad Biol Med 2012;53:1689–1696.
28. S.Elchuri, T.D.Oberley, W.Qi, R.S.Eisenstein, L.Jackson Roberts, H.Van Remmen,. CuZnSOD deficiency leads to persistent and widespread oxidative damage and hepatocarcinogenesis later in life. Oncogene 2005;24:367–380.
29. M.L.Sentman, M.Granstrom, H.Jakobson, A.Reaume, S.Basu, S.L.Marklund Phenotypes of mice lacking extracellular superoxide dismutase and copper- and zinc-containing superoxide dismutase. J Biol Chem 2006;281:6904–6909.
30. R.R.Starzynski, P.Lipinski, J.C.Drapier, A.Diet, E.Smuda, T.Bartlomiejczyk,. Down-regulation of iron regulatory protein 1 activities and expression in superoxide dismutase 1 knock-out mice is not associated with alterations in iron metabolism. J Biol Chem 2005;280: 4207–4212.
31. R.R.Starzynski, F.Canonne-Hergaux, A.Willemetz, M.A.Gralak, J.Wolinski, A.Stys,. Haemolytic anaemia and alterations in hepatic iron metabolism in aged mice lacking Cu,Zn-superoxide dismutase. Biochem J 2009;420:383–390.
32. D.Yoshihara, N.Fujiwara, S.Kato, H.Sakiyama, H.Eguchi, K.Suzuki Alterations in renal iron metabolism caused by a copper/zinc-superoxide dismutase deficiency. Free Radic Res 2012;46:750–757.
33. S.Toyokuni Mysterious link between iron overload and CDKN2A/2B. J Clin Biochem Nutr 2011;48:46–49.
34. A.Finkelstein, G.Kunis, A.Seksenyan, A.Ronen, T.Berkutzki, D.Azoulay,. Abnormal changes in NKT cells, the IGF-1 axis, and liver pathology in an animal model of ALS. PLoS One 2011;6:e22374.
35. X.Wang, M.Z.Vatamaniuk, C.A.Roneker, M.P.Pepper, L.G.Hu, R.A.Simmons, X.G.Lei Knockouts of SOD1 and GPX1 exert different impacts on murine islet function and pancreatic integrity. Antioxid Redox Signal 2011;14:391–401.
36. P.I.Moreira, M.A.Smith, X.Zhu, A.Nunomura, R.J.Castellani, G.Perry Oxidative stress and neurodegeneration. Ann NY Acad Sci 2005;1043:545–552.
37. M.P.Wautier, O.Chappey, S.Corda, D.M.Stern, A.M.Schmidt, J.L.Wautier Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE. Am J Physiol Endocrinol Metab 2001;280:E685–E694.
38. N.Reiniger, K.Lau, D.McCalla, B.Eby, B.Cheng, Y.Lu,. Deletion of the receptor for advanced glycation end products reduces glomerulosclerosis and preserves renal function in the diabetic OVE26 mouse. Diabetes 2010;59:2043–2054.
39. K.Nagata, N.Hosokawa Regulation and function of collagen-specific molecular chaperone, HSP47. Cell Struct Funct 1996;21:425–430.
40. K.Nagata Expression and function of heat shock protein 47: A collagen-specific molecular chaperone in the endoplasmic reticulum. Matrix Biol 1998;16:379–386.
41. T.Koide, S.Asada, K.Nagata Substrate recognition of collagen-specific molecular chaperone HSP47. Structural requirements and binding regulation. J Biol Chem 1999;274:34523–34526.
42. T.Koide, A.Aso, T.Yorihuzi, K.Nagata Conformational requirements of collagenous peptides for recognition by the chaperone protein HSP47. J Biol Chem 2000;275:27957–27963.
43. T.Koide, Y.Takahara, S.Asada, K.Nagata Xaa-Arg-Gly triplets in the collagen triple helix are dominant binding sites for the molecular chaperone HSP47. J Biol Chem 2002;277:6178–6182.
44. J.P.Iredale, R.C.Benyon, M.J.Arthur, W.F.Ferris, R.Alcolado, P.J.Winwood,. Tissue inhibitor of metalloproteinase-1 messenger RNA expression is enhanced relative to interstitial collagenase messenger RNA in experimental liver injury and fibrosis. Hepatology 1996;24:176–184.
45. J.P.Iredale, G.Murphy, R.M.Hembry, S.L.Friedman, M.J.Arthur Human hepatic lipocytes synthesize tissue inhibitor of metalloproteinases-1. Implications for regulation of matrix degradation in liver. J Clin Invest 1992;90:282–287.
46. J.P.Iredale Models of liver fibrosis: Exploring the dynamic nature of inflammation and repair in a solid organ. J Clin Invest 2007;117:539–548.
47. R.C.Benyon, J.P.Iredale, S.Goddard, P.J.Winwood, M.J.Arthur Expression of tissue inhibitor of metalloproteinases 1 and 2 is increased in fibrotic human liver. Gastroenterology 1996;110:821–831.
48. H.Yoshiji, S.Kuriyama, J.Yoshii, Y.Ikenaka, R.Noguchi, T.Nakatani,. Tissue inhibitor of metalloproteinases-1 attenuates spontaneous liver fibrosis resolution in the transgenic mouse. Hepatology 2002;36:850–860.
49. J.Iredale Defining therapeutic targets for liver fibrosis: Exploiting the biology of inflammation and repair. Pharmacol Res 2008;58:129–136.
50. P.Ramachandran, J.P.Iredale Reversibility of liver fibrosis. Ann Hepatol 2009;8:283–291.
51. H.Hyogo, S.Yamagishi, K.Iwamoto, K.Arihiro, M.Takeuchi, T.Sato,. Elevated levels of serum advanced glycation end products in patients with non-alcoholic steatohepatitis. J Gastroenterol Hepatol 2007;22:1112–1119.
52. J.X.Jiang, X.Chen, H.Fukada, N.Serizawa, S.Devaraj, N.J.Torok Advanced glycation endproducts induce fibrogenic activity in nonalcoholic steatohepatitis by modulating TNF-alpha-converting enzyme activity in mice. Hepatology 2013;58:1339–1348.
53. P.R.Smith, P.J.Thornalley Mechanism of the degradation of non-enzymatically glycated proteins under physiological conditions. Studies with the model fructosamine, N epsilon-(1-deoxy-d-fructos-1-yl)hippuryl-lysine. Eur J Biochem 1992;210:729–739.
54. R.Nagai, K.Ikeda, T.Higashi, H.Sano, Y.Jinnouchi, T.Araki, S.Horiuchi Hydroxyl radical mediates N epsilon-(carboxymethyl)lysine formation from Amadori product. Biochem Biophys Res Commun 1997;234:167–172.
55. M.U.Ahmed, S.R.Thorpe, J.W.Baynes Identification of N epsilon-carboxymethyllysine as a degradation product of fructoselysine in glycated protein. J Biol Chem 1986;261:4889–4894.